MetaVia
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MetaVia and other ETFs, options, and stocks.About MTVA
MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing novel pharmaceuticals to treat cardiometabolic diseases. It is developing DA-1726 for the treatment of various cardiometabolic conditions, with potential in both Metabolic and Alcohol-Associated Liver Disease (MetALD) and Alcohol-Associated Liver Disease (ALD), and is advancing vanoglipel (DA-1241) in combination with resmetirom for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH).
MTVA Key Statistics
Stock Snapshot
MetaVia(MTVA) stock is priced at $1.40, giving the company a market capitalization of 9.49M. It carries a P/E multiple of -0.36.
On 2026-11-12, MetaVia(MTVA) stock moved within a range of $1.38 to $1.61. With shares now at $1.40, the stock is trading +1.4% above its intraday low and -13.0% below the session's peak.
Trading volume for MetaVia(MTVA) stock has reached 129.44K, versus its average volume of 317.21K.
The stock's 52-week range extends from a low of $0.97 to a high of $13.42.
The stock's 52-week range extends from a low of $0.97 to a high of $13.42.
MTVA News
An announcement from MetaVia ( (MTVA) ) is now available. On November 5, 2026, MetaVia reported positive interim results from Part 3B of DA-1726’s Phase 1 tria...
...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.